|
Name |
Tubingensin A
|
Molecular Formula | C28H35NO | |
IUPAC Name* |
(16S,17R,20S,21R)-16,17-dimethyl-21-(4-methylpent-3-enyl)-10-azapentacyclo[11.8.0.03,11.04,9.016,21]henicosa-1,3(11),4,6,8,12-hexaen-20-ol
|
|
SMILES |
C[C@@H]1CC[C@@H]([C@@]2([C@]1(CCC3=CC4=C(C=C32)C5=CC=CC=C5N4)C)CCC=C(C)C)O
|
|
InChI |
InChI=1S/C28H35NO/c1-18(2)8-7-14-28-23-17-22-21-9-5-6-10-24(21)29-25(22)16-20(23)13-15-27(28,4)19(3)11-12-26(28)30/h5-6,8-10,16-17,19,26,29-30H,7,11-15H2,1-4H3/t19-,26+,27+,28-/m1/s1
|
|
InChIKey |
BWCQRIGHZTXFEA-AIERRPMVSA-N
|
|
Synonyms |
Tubingensin A; (1S,4R,4aS,13bR)-4,4a-dimethyl-13b-(4-methylpent-3-en-1-yl)-2,3,4,4a,5,6,8,13b-octahydro-1H-naphtho[2,1-b]carbazol-1-ol
|
|
CAS | NA | |
PubChem CID | 14413056 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 401.6 | ALogp: | 7.7 |
HBD: | 2 | HBA: | 1 |
Rotatable Bonds: | 3 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 36.0 | Aromatic Rings: | 5 |
Heavy Atoms: | 30 | QED Weighted: | 0.456 |
Caco-2 Permeability: | -4.998 | MDCK Permeability: | 0.00001260 |
Pgp-inhibitor: | 0.997 | Pgp-substrate: | 0.045 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.983 |
30% Bioavailability (F30%): | 0.986 |
Blood-Brain-Barrier Penetration (BBB): | 0.081 | Plasma Protein Binding (PPB): | 96.76% |
Volume Distribution (VD): | 6.112 | Fu: | 3.58% |
CYP1A2-inhibitor: | 0.857 | CYP1A2-substrate: | 0.386 |
CYP2C19-inhibitor: | 0.44 | CYP2C19-substrate: | 0.556 |
CYP2C9-inhibitor: | 0.539 | CYP2C9-substrate: | 0.902 |
CYP2D6-inhibitor: | 0.673 | CYP2D6-substrate: | 0.889 |
CYP3A4-inhibitor: | 0.712 | CYP3A4-substrate: | 0.218 |
Clearance (CL): | 9.784 | Half-life (T1/2): | 0.036 |
hERG Blockers: | 0.885 | Human Hepatotoxicity (H-HT): | 0.671 |
Drug-inuced Liver Injury (DILI): | 0.048 | AMES Toxicity: | 0.391 |
Rat Oral Acute Toxicity: | 0.893 | Maximum Recommended Daily Dose: | 0.983 |
Skin Sensitization: | 0.955 | Carcinogencity: | 0.354 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.534 |
Respiratory Toxicity: | 0.949 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001931 | 0.470 | D0W6DG | 0.300 | ||||
ENC002079 | 0.444 | D0IT2X | 0.278 | ||||
ENC003874 | 0.405 | D03VFL | 0.273 | ||||
ENC002423 | 0.385 | D01JGV | 0.270 | ||||
ENC005121 | 0.379 | D0U7GP | 0.270 | ||||
ENC002422 | 0.374 | D0H4JM | 0.270 | ||||
ENC003299 | 0.359 | D08VRO | 0.263 | ||||
ENC005120 | 0.346 | D06CWH | 0.252 | ||||
ENC003932 | 0.340 | D0T7ZQ | 0.250 | ||||
ENC005883 | 0.339 | D0NS6H | 0.248 |